|Antifungal Ergosterol Synthesis Inhibitors|
Credits: 1.25 Post-Assessment Questions: 10
Release Date: 5 Oct 2020
Expiration Date: 11 Feb 2022
Last Reviewed: 11 Feb 2021
Estimated Time To Finish: 75 Minutes
The ergosterol inhibitor class of medications ("conazoles") is used in the management and treatment of fungal infections. These drugs inhibit ergosterol in the cell membrane to help kill fungi. This drug comes in both topical and systemic formulas. This drug can cause hepatotoxicity and should, therefore, be monitored via inter-professional communication. Both physicians, pharmacists, and other providers should look closely at the patient's medical history and list of medications to make sure there is no history of liver failure or drug-drug interactions.
This activity has been designed to meet the educational needs of physicians.
At the conclusion of this activity, the learner will be better able to:
Each author, editor, faculty and planning committee member have completed a disclosure form indicating that neither they nor their spouse/partner has a financial interest/arrangement or affiliation that could be perceived as a real or apparent conflict of interest related to the content of this activity.
COMMERCIAL SUPPORT: This activity has received NO commercial support.
Authors: Elizabeth Herrick
Editors: Muhammad Hashmi
Editors-In-Chief: Nisha Kumar
Chief Medical Reviewer: Charles Preuss
Nurse Planner/Reviewer/Editor: Lisa Haddad
Nurse Planner/Reviewer/Editor: Bernadette Makar
Nurse Planner/Reviewer/Editor: Dorothy Caputo
Pharmacy Planner/Reviewer/Editor: Mark Pellegrini
Physician Planner/Reviewer/Editor: Scott Dulebohn
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Quillen College of Medicine, East Tennessee State University, and StatPearls, LLC. The Quillen College of Medicine, East Tennessee State University is accredited by the ACCME to provide continuing medical education for physicians.
Quillen College of Medicine, East Tennessee State University designates this activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.
Medium or Media Used:
Instructions for Credit
StatPearls and ETSU adhere to ACCME Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and ETSU that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.